Regulations on extractables & leachables studies for pharmaceutical packaging

>EU Pharmacopeia Chapter 3, incl. Supplement 5.1, 5.2 & 5.3

>USP e.g. <381> for elastomers, <661> for polymer characterisation

>FDA Guidance for Industry: Container Closure Systems for Packing Human Drugs and Biologics

>FDA Guidance for Industry: Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products

>FDA Guidance for Industry: Nasal Spray and Inhalation Solution, Suspension and Spray Drug Products

>EMEA CPMP/QWP/4359/03, Guideline on Immediate Packing Materials

>EMEA CPMP/QWP/2845/00, Note for Guidance for Metered Dose Inhalation Products Packing Materials

>EMEA CPMP/QWP/158/96, Note for Guidance on Dry Powder Inhaler

.fairmate_js_notification_overlay { z-index: 9000; position: fixed; top: 0; bottom: 0; left: 0; right: 0; background-color: rgb(204, 204, 204); background-color: rgba(204, 204, 204, 0.7); } .fairmate_js_notification_popup_dlg { background-color: #fff !important; margin-left: auto; margin-right: auto; width: 570px; margin-top: 10%; } .fairmate_js_notification_popup_header { display: flex; justify-content: center; padding: 10px; } .fairmate_js_notification_popup_content { padding: 10px 60px 30px; } .fairmate_js_notification_popup_footer { display: flex; justify-content: center; padding-bottom: 30px; }

This page requires JavaScript

To use the full function of this web site, JavaScript needs to be enabled in your browser.

This is how you enable JavaScript in your browser settings:
Read instruction